| Cayman Chemical Company | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (734) 971-3335 | |||
![]() |
sales@caymanchem.com | |||
| Chemical manufacturer | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (831) 457-3800 | |||
![]() |
scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Circulatory system medication |
|---|---|
| Name | Mozavaptan hydrochloride |
| Synonyms | N-[4-[[5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methylbenzamide hydrochloride |
| Molecular Structure | ![]() |
| Molecular Formula | C27H29N3O2.HCl |
| Molecular Weight | 464.00 |
| CAS Registry Number | 138470-70-9 |
| EC Number | 689-426-1 |
| Hazard Classification | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||
| SDS | Available | ||||||||||||
| Market Analysis Reports |
| List of Reports Available for Mozavaptan hydrochloride |